J.P. Sevilla

461 total citations
19 papers, 209 citations indexed

About

J.P. Sevilla is a scholar working on Epidemiology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, J.P. Sevilla has authored 19 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in General Health Professions and 7 papers in Economics and Econometrics. Recurrent topics in J.P. Sevilla's work include Global Health Care Issues (6 papers), Pneumonia and Respiratory Infections (5 papers) and Vaccine Coverage and Hesitancy (4 papers). J.P. Sevilla is often cited by papers focused on Global Health Care Issues (6 papers), Pneumonia and Respiratory Infections (5 papers) and Vaccine Coverage and Hesitancy (4 papers). J.P. Sevilla collaborates with scholars based in United States, Belgium and United Kingdom. J.P. Sevilla's co-authors include David E. Bloom, Victoria Y. Fan, Mark Jit, Daniel Cadarette, Marc Lipsitch, Reiko Sato, Larry Rosenberg, Salal Humair, James Trussell and Daniel L. Tortorice and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Science Translational Medicine and Current Opinion in Immunology.

In The Last Decade

J.P. Sevilla

18 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Sevilla United States 6 80 75 54 48 33 19 209
Atif Riaz Pakistan 10 93 1.2× 71 0.9× 38 0.7× 76 1.6× 53 1.6× 24 287
Oluwatosin Olu-Abiodun Nigeria 7 66 0.8× 134 1.8× 22 0.4× 87 1.8× 75 2.3× 16 311
Natalie C Galles United States 2 169 2.1× 93 1.2× 15 0.3× 21 0.4× 89 2.7× 3 246
Amanda Deen United States 1 169 2.1× 93 1.2× 15 0.3× 21 0.4× 89 2.7× 2 245
Charity Oga‐Omenka Canada 11 27 0.3× 115 1.5× 31 0.6× 43 0.9× 179 5.4× 26 281
Boubacar Dieng Nigeria 8 113 1.4× 77 1.0× 35 0.6× 47 1.0× 50 1.5× 25 254
Morgane Donadel United States 7 77 1.0× 118 1.6× 23 0.4× 23 0.5× 45 1.4× 11 192
Robert Swanson United States 6 176 2.2× 108 1.4× 9 0.2× 55 1.1× 80 2.4× 7 262
Pierre Muhoza United States 6 76 0.9× 60 0.8× 8 0.1× 52 1.1× 43 1.3× 9 195
Katrina Clark Australia 8 137 1.7× 109 1.5× 14 0.3× 35 0.7× 71 2.2× 15 211

Countries citing papers authored by J.P. Sevilla

Since Specialization
Citations

This map shows the geographic impact of J.P. Sevilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Sevilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Sevilla more than expected).

Fields of papers citing papers by J.P. Sevilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Sevilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Sevilla. The network helps show where J.P. Sevilla may publish in the future.

Co-authorship network of co-authors of J.P. Sevilla

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Sevilla. A scholar is included among the top collaborators of J.P. Sevilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Sevilla. J.P. Sevilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sevilla, J.P., Daniel L. Tortorice, David Kantor, et al.. (2024). Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK. The European Journal of Health Economics. 25(7). 1133–1146.
2.
Sevilla, J.P., et al.. (2024). The global health and economic value of COVID-19 vaccination. BMJ Global Health. 9(9). e015031–e015031. 1 indexed citations
3.
Sevilla, J.P.. (2023). COVID-19 vaccines should be evaluated from the societal perspective. Journal of Medical Economics. 27(1). 1–9. 2 indexed citations
4.
Sevilla, J.P.. (2023). Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children program. Journal of Medical Economics. 26(1). 991–997. 5 indexed citations
5.
Sevilla, J.P.. (2022). The value of vaccines. Current Opinion in Immunology. 78. 102243–102243. 5 indexed citations
6.
Sevilla, J.P., et al.. (2022). Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient population. Journal of Medical Economics. 25(1). 1051–1060. 4 indexed citations
7.
Sevilla, J.P., et al.. (2022). Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Human Vaccines & Immunotherapeutics. 18(6). 2114252–2114252. 3 indexed citations
8.
Sevilla, J.P., et al.. (2020). Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey. Human Vaccines & Immunotherapeutics. 16(8). 1923–1936. 14 indexed citations
9.
Bloom, David E., et al.. (2020). Valuing Productive Non-market Activities of Older Adults in Europe and the US. De Economist. 168(2). 153–181. 17 indexed citations
10.
Sevilla, J.P., Daniel L. Tortorice, David Kantor, et al.. (2019). PIN43 LIFECYCLE-MODEL-BASED ECONOMIC EVALUATION OF INFANT MENINGITIS B VACCINATION IN THE UK. Value in Health. 22. S647–S647. 5 indexed citations
11.
Sevilla, J.P., et al.. (2019). Indirect costs of adult pneumococcal disease and productivity-based rate of return to PCV13 vaccination for older adults and elderly diabetics in Denmark. The Journal of the Economics of Ageing. 14. 100203–100203. 3 indexed citations
12.
Bloom, David E., Victoria Y. Fan, & J.P. Sevilla. (2018). The broad socioeconomic benefits of vaccination. Science Translational Medicine. 10(441). 69 indexed citations
13.
Bloom, David E., Daniel Cadarette, & J.P. Sevilla. (2018). Epidemias y economía: las enfermedades infecciosas nuevas y recurrentes pueden tener amplias repercusiones económicas. 55(2). 46–49. 1 indexed citations
14.
Sevilla, J.P.. (2018). MCDA or preference-based social welfare functions?. Cost Effectiveness and Resource Allocation. 16(S1). 41–41. 1 indexed citations
15.
Sevilla, J.P., David E. Bloom, Daniel Cadarette, Mark Jit, & Marc Lipsitch. (2018). Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR. Proceedings of the National Academy of Sciences. 115(51). 12911–12919. 50 indexed citations
16.
17.
Sevilla, J.P.. (2015). Value Pricing by Developing Countries and Its Impact on Allocative and Dynamic Efficiency in the Global Pharmaceutical Industry. SSRN Electronic Journal. 1 indexed citations
18.
Bloom, David E., Salal Humair, Larry Rosenberg, J.P. Sevilla, & James Trussell. (2014). A Demographic Dividend for Sub-Saharan Africa: Source, Magnitude, and Realization. SSRN Electronic Journal. 16 indexed citations
19.
Canning, David, et al.. (2001). Demographic transition and economic opportunity: the case of Jordan.. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atif Riaz Breakdown of academic impact, for papers by Oluwatosin Olu-Abiodun Breakdown of academic impact, for papers by Natalie C Galles Breakdown of academic impact, for papers by Amanda Deen Breakdown of academic impact, for papers by Charity Oga‐Omenka Breakdown of academic impact, for papers by Boubacar Dieng Breakdown of academic impact, for papers by Morgane Donadel Breakdown of academic impact, for papers by Robert Swanson Breakdown of academic impact, for papers by Pierre Muhoza Breakdown of academic impact, for papers by Katrina Clark
Rankless by CCL
2026